Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

Decline of Haemophilus influenzae type b disease in a region of high risk: impact of passive and active immunization.

Singleton RJ, Davidson NM, Desmet IJ, Berner JE, Wainwright RB, Bulkow LR, Lilly CM, Siber GR.

Pediatr Infect Dis J. 1994 May;13(5):362-7.

PMID:
8072817
2.

Prevention of Haemophilus influenzae type b infections in high-risk infants treated with bacterial polysaccharide immune globulin.

Santosham M, Reid R, Ambrosino DM, Wolff MC, Almeido-Hill J, Priehs C, Aspery KM, Garrett S, Croll L, Foster S, et al.

N Engl J Med. 1987 Oct 8;317(15):923-9.

PMID:
2442610
3.

Prevention of Haemophilus influenzae type b disease.

Santosham M.

Vaccine. 1993;11 Suppl 1:S52-7. Review.

PMID:
8447177
4.

The Alaska Haemophilus influenzae type b experience: lessons in controlling a vaccine-preventable disease.

Singleton R, Hammitt L, Hennessy T, Bulkow L, DeByle C, Parkinson A, Cottle TE, Peters H, Butler JC.

Pediatrics. 2006 Aug;118(2):e421-9.

PMID:
16882783
5.

Haemophilus influenzae type b conjugate vaccines: a review of efficacy data.

Heath PT.

Pediatr Infect Dis J. 1998 Sep;17(9 Suppl):S117-22. Review.

PMID:
9781743
6.

Postlicensure effectiveness of the Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer-membrane protein complex conjugate vaccine among Navajo children.

Harrison LH, Tajkowski C, Croll J, Reid R, Hu D, Brenneman G, Weatherholtz RC, Santosham M.

J Pediatr. 1994 Oct;125(4):571-6.

PMID:
7931875
7.

Evaluation of bacterial polysaccharide immune globulin for the treatment or prevention of Haemophilus influenzae type b and pneumococcal disease.

Siber GR, Thompson C, Reid GR, Almeido-Hill J, Zacher B, Wolff M, Santosham M.

J Infect Dis. 1992 Jun;165 Suppl 1:S129-33. Review.

PMID:
1588146
8.

Large scale, postlicensure, selective vaccination of Chilean infants with PRP-T conjugate vaccine: practicality and effectiveness in preventing invasive Haemophilus influenzae type b infections.

Lagos R, Horwitz I, Toro J, San Martin O, Abrego P, Bustamante C, Wasserman SS, Levine OS, Levine MM.

Pediatr Infect Dis J. 1996 Mar;15(3):216-22.

PMID:
8852909
9.

The immunogenicity of three Haemophilus influenzae type B conjugate vaccines after a primary vaccination series in Philippine infants.

Capeding MR, Nohynek H, Pascual LG, Kayhty H, Sombrero LT, Eskola J, Ruutu P.

Am J Trop Med Hyg. 1996 Nov;55(5):516-20.

PMID:
8940983
10.

Eradication of Haemophilus influenzae type b disease in southern California. Kaiser-UCLA Vaccine Study Group.

Vadheim CM, Greenberg DP, Eriksen E, Hemenway L, Bendana N, Mascola L, Ward JI.

Arch Pediatr Adolesc Med. 1994 Jan;148(1):51-6.

PMID:
8143010
11.
12.

Immunogenicity and safety of four different doses of Haemophilus influenzae type b-tetanus toxoid conjugated vaccine, combined with diphtheria-tetanus-pertussis vaccine (DTP-Hib), in Indonesian infants.

Punjabi NH, Richie EL, Simanjuntak CH, Harjanto SJ, Wangsasaputra F, Arjoso S, Rofiq A, Prijanto M, Julitasari, Yela U, Herzog C, Cryz SJ.

Vaccine. 2006 Mar 10;24(11):1776-85. Epub 2005 Oct 27.

PMID:
16303216
13.

The biology of Haemophilus influenzae type b vaccination failure.

Holmes SJ, Granoff DM.

J Infect Dis. 1992 Jun;165 Suppl 1:S121-8. Review.

PMID:
1588145
14.

Haemophilus influenzae type b-specific antibody in infants after maternal immunization.

Englund JA, Glezen WP, Thompson C, Anwaruddin R, Turner CS, Siber GR.

Pediatr Infect Dis J. 1997 Dec;16(12):1122-30.

PMID:
9427456
15.

Haemophilus influenzae type b disease: impact and effectiveness of diphtheria-tetanus toxoids-acellular pertussis (-inactivated poliovirus)/H. influenzae type b combination vaccines.

Schmitt HJ, von Kries R, Hassenpflug B, Hermann M, Siedler A, Niessing W, Clemens R, Weil J.

Pediatr Infect Dis J. 2001 Aug;20(8):767-74.

PMID:
11734739
16.

Prevention of Haemophilus influenzae type b colonization by vaccination: correlation with serum anti-capsular IgG concentration.

Fernandez J, Levine OS, Sanchez J, Balter S, LaClaire L, Feris J, Romero-Steiner S.

J Infect Dis. 2000 Nov;182(5):1553-6. Epub 2000 Oct 9.

PMID:
11023481
17.

Comparative immunogenicity of four Haemophilus influenzae type b conjugate vaccines in Alaska Native infants.

Bulkow LR, Wainwright RB, Letson GW, Chang SJ, Ward JI.

Pediatr Infect Dis J. 1993 Jun;12(6):484-92.

PMID:
8345981
18.

Comparison of naturally acquired and vaccine-induced antibodies to Haemophilus influenzae type b capsular polysaccharide.

Jelonek MT, Chang SJ, Chiu CY, Park MK, Nahm MH, Ward JI.

Infect Immun. 1993 Dec;61(12):5345-50.

19.

Safety and antibody persistence following Haemophilus influenzae type b conjugate or pneumococcal polysaccharide vaccines given before pregnancy in women of childbearing age and their infants.

Santosham M, Englund JA, McInnes P, Croll J, Thompson CM, Croll L, Glezen WP, Siber GR.

Pediatr Infect Dis J. 2001 Oct;20(10):931-40.

PMID:
11642626

Supplemental Content

Support Center